Woojung Bio Non-Executive Director Sangsu Lee Acquires 8,247 Shares via Open Market Purchase, Signaling Confidence with Minimal Ownership Change

Woojung Bio non-registered executive director Sangsu Lee acquired 8,247 common shares through open market purchases from May 29 to June 4, 2026.
The acquisition prices ranged from 2,537 KRW to 2,865 KRW per share, higher than the current market price of 2,485 KRW, signaling management's belief in undervaluation.
The acquired shares represent only 0.05% of total outstanding shares of 16,829,576, limiting direct impact on stock price and shareholder value.
No treasury stock acquisition or cancellation was announced; this filing is solely a personal shareholding change report and does not indicate any change in corporate capital policy.
[AI Summary]Insider Lee's open market purchase is small in scale with negligible short-term price impact but does convey insider confidence. Without corporate capital structure changes or additional shareholder return policies, investors should focus on other catalysts.